Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Tagworks Pharmaceuticals is a privately held biotech company
RxLightning automates the manual enrollment process of starting a patient on specialty medications.
Amphista Therapeutics operates as a biopharmaceutical company.
Bringing clarity to cancer. Working to ensure that everyone touched by cancer has a clear path to the right care.
Anokion is harnessing the power of natural immune equilibrium to develop solutions for antigen-specific immune tolerance.
Alladapt Immunotherapeutics is a privately held biopharmaceutical company developing prescription therapeutics targeting food allergy.
Transforming medical data into predictive algorithms without code
NuvoAir is a value-based specialty management platform transforming the diagnosis and management of chronic heart and lung conditions.
SiO2 Materials Science is a plastic container designing company.
Anaveon is a developing IL-2 complexes which selectively promote effector T cell functions.
Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.
CODA Biotherapeutics develops a chemogenetic platform designed to modulate neuronal activity.
Kedalion Therapeutics is a biotechnology company that develops and commercializes transformative topical ophthalmic therapies.
Dunad Therapeutics is a biopharmaceutical company focusing on the development of next-generation targeted protein degradation therapies.
Soteria is a biotechnology company that develops immunotherapies to treat cancer patients
Ayala Pharmaceuticals a clinical-stage biopharmaceutical company focused on developing and commercializing small molecule therapeutics.
Aspen RxHealth is a service powered by an app-based platform that connects pharmacists with patients.
AccessNow is a platform that serves as a go-to resource for accessibility information.
Arctos Medical is a developed gene therapy that does not correct rare genetic eye diseases but much more common cases of blindness.
DescriptionIFM Therapeutics is a pharmaceutical company focused on developing biological treatments for autoimmune diseases.
Forendo Pharma is a developer of novel drugs intended for the treatment of urological and other endocrinological diseases.
Anthos Therapeutics is a biopharmaceutical company that specializes in the treatment of cardiovascular and metabolic diseases.
Aelin Therapeutics is a provider of a biotherapeutics platform technology called pept-ins that are intended to harnesses.
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Novartis has invested in 99 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Novartis's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 20 different industry categories.
Among tracked funding rounds, Anthos Therapeutics received $250.0M in a Series A round. Novartis's total known invested capital is $3.8B.
Novartis's average investment size is $60.5M across its portfolio of 99 companies.
Recent Novartis portfolio additions include Tagworks Pharmaceuticals, RxLightning, Amphista Therapeutics, COTA Healthcare, Anokion. These companies were founded in 2020 or later.